Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
$5.58
+4.1%
$5.25
$4.22
$8.90
$63.89M0.248,020 shs2,800 shs
Invacare Co. stock logo
IVC
Invacare
$0.50
$0.33
$2.53
$20.01M0.38240,305 shs33,301 shs
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$17.20
+3.1%
$16.83
$10.60
$19.66
$126.76M0.4722,849 shs20,857 shs
RTI Surgical Holdings, Inc. stock logo
RTIX
RTI Surgical
$3.14
$3.14
$1.46
$5.40
$234.25M2.14622,541 shs686,036 shs
Sientra, Inc. stock logo
SIEN
Sientra
$0.43
$0.16
$4.94
$2.08M2.044.15 million shs3.44 million shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
-0.92%+2.29%+2.29%+7.20%-23.43%
Invacare Co. stock logo
IVC
Invacare
0.00%0.00%0.00%0.00%0.00%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
-1.18%+1.71%+6.71%-7.33%+44.13%
RTI Surgical Holdings, Inc. stock logo
RTIX
RTI Surgical
0.00%0.00%0.00%0.00%0.00%
Sientra, Inc. stock logo
SIEN
Sientra
0.00%0.00%0.00%-71.01%-87.48%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
2.581 of 5 stars
3.55.00.00.02.60.00.6
Invacare Co. stock logo
IVC
Invacare
N/AN/AN/AN/AN/AN/AN/AN/A
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
4.8565 of 5 stars
3.53.01.74.93.71.71.9
RTI Surgical Holdings, Inc. stock logo
RTIX
RTI Surgical
N/AN/AN/AN/AN/AN/AN/AN/A
Sientra, Inc. stock logo
SIEN
Sientra
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
3.00
Buy$11.0097.13% Upside
Invacare Co. stock logo
IVC
Invacare
N/AN/AN/AN/A
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
3.00
Buy$22.0027.91% Upside
RTI Surgical Holdings, Inc. stock logo
RTIX
RTI Surgical
N/AN/AN/AN/A
Sientra, Inc. stock logo
SIEN
Sientra
2.00
HoldN/AN/A

Current Analyst Ratings

Latest LAKE, SIEN, RTIX, IVC, and CLGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/24/2024
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$22.00
4/5/2024
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$11.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
$10.96M5.83N/AN/A$2.47 per share2.26
Invacare Co. stock logo
IVC
Invacare
$872.46M0.00N/A0.77$5.54 per share0.00
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$124.69M1.02$1.42 per share12.15$16.76 per share1.03
RTI Surgical Holdings, Inc. stock logo
RTIX
RTI Surgical
$308.38M0.76$0.30 per share10.31$2.89 per share1.09
Sientra, Inc. stock logo
SIEN
Sientra
$90.55M0.00N/AN/A($0.04) per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
-$7.02M-$0.64N/AN/AN/A-64.05%-22.17%-18.84%5/22/2024 (Estimated)
Invacare Co. stock logo
IVC
Invacare
-$45.56M-$2.18N/AN/AN/A-9.99%-37.76%-7.18%N/A
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$5.43M$0.7124.238.73N/A4.33%6.63%5.45%6/5/2024 (Estimated)
RTI Surgical Holdings, Inc. stock logo
RTIX
RTI Surgical
-$211.64M-$0.16N/AN/AN/A-70.56%N/AN/AN/A
Sientra, Inc. stock logo
SIEN
Sientra
-$73.31M-$5.57N/AN/AN/A-65.93%N/A-40.45%N/A

Latest LAKE, SIEN, RTIX, IVC, and CLGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/10/2024Q4 2024
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$0.30$0.22-$0.08$0.57$32.50 million$31.20 million    
4/4/2024Q4 2023
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
N/A-$0.42-$0.42-$0.42N/A$0.30 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
N/AN/AN/AN/AN/A
Invacare Co. stock logo
IVC
Invacare
N/AN/AN/AN/AN/A
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$0.120.70%N/A16.90%N/A
RTI Surgical Holdings, Inc. stock logo
RTIX
RTI Surgical
N/AN/AN/AN/AN/A
Sientra, Inc. stock logo
SIEN
Sientra
N/AN/AN/AN/AN/A

Latest LAKE, SIEN, RTIX, IVC, and CLGN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/1/2024
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
Quarterly$0.030.66%2/14/20242/15/20242/22/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
N/A
8.62
8.40
Invacare Co. stock logo
IVC
Invacare
4.82
1.32
0.78
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
0.01
5.53
2.74
RTI Surgical Holdings, Inc. stock logo
RTIX
RTI Surgical
N/AN/AN/A
Sientra, Inc. stock logo
SIEN
Sientra
N/A
0.57
0.31

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
21.69%
Invacare Co. stock logo
IVC
Invacare
59.87%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
71.69%
RTI Surgical Holdings, Inc. stock logo
RTIX
RTI Surgical
60.97%
Sientra, Inc. stock logo
SIEN
Sientra
15.38%

Insider Ownership

CompanyInsider Ownership
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
9.60%
Invacare Co. stock logo
IVC
Invacare
6.90%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
6.10%
RTI Surgical Holdings, Inc. stock logo
RTIX
RTI Surgical
3.70%
Sientra, Inc. stock logo
SIEN
Sientra
1.53%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
7311.45 million10.35 millionOptionable
Invacare Co. stock logo
IVC
Invacare
3,00037.76 million35.15 millionOptionable
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
1,7507.37 million6.92 millionOptionable
RTI Surgical Holdings, Inc. stock logo
RTIX
RTI Surgical
89174.60 millionN/AOptionable
Sientra, Inc. stock logo
SIEN
Sientra
30411.96 million11.78 millionOptionable

LAKE, SIEN, RTIX, IVC, and CLGN Headlines

SourceHeadline
Tiger Aesthetics Medical, LLC Acquires Assets of Sientra, Inc.Tiger Aesthetics Medical, LLC Acquires Assets of Sientra, Inc.
bignewsnetwork.com - April 24 at 6:29 PM
California-based manufacturer of breast implants closing Franklin facility as part of bankruptcyCalifornia-based manufacturer of breast implants closing Franklin facility as part of bankruptcy
biztimes.com - April 22 at 2:14 PM
Sientra Inc SIENQSientra Inc SIENQ
morningstar.com - April 22 at 12:31 AM
Nuance Medical Completes Acquisition of BIOCORNEUM Scar Treatment Brand, to Become a Part of the Biodermis PortfolioNuance Medical Completes Acquisition of BIOCORNEUM Scar Treatment Brand, to Become a Part of the Biodermis Portfolio
finance.yahoo.com - April 18 at 3:40 PM
Aesthetic Implants Market: In-Depth Analysis, Emerging Trends, Growth Drivers, and Forecasts up to 2033Aesthetic Implants Market: In-Depth Analysis, Emerging Trends, Growth Drivers, and Forecasts up to 2033
pharmiweb.com - April 13 at 7:57 AM
Breast Implants Market to Reach USD 7.8 Billion by 2032, CAGR 6.7% | Marketresearch.bizBreast Implants Market to Reach USD 7.8 Billion by 2032, CAGR 6.7% | Marketresearch.biz
pharmiweb.com - April 12 at 5:47 AM
Nasdaq (NDAQ) Initiated with a Buy at BarclaysNasdaq (NDAQ) Initiated with a Buy at Barclays
markets.businessinsider.com - April 11 at 7:34 AM
Medical Aesthetics Market Future Projections: USD 51.7 Billion By 2032 With A Consistent 14.7% Growth RateMedical Aesthetics Market Future Projections: USD 51.7 Billion By 2032 With A Consistent 14.7% Growth Rate
pharmiweb.com - April 8 at 4:33 PM
Global Extremity Tissue Expanders Industry Expected to Grow at a Startling 6.3% CAGR to Reach US$ 1,842.6 Million by 2028 | FMI AnalysisGlobal Extremity Tissue Expanders Industry Expected to Grow at a Startling 6.3% CAGR to Reach US$ 1,842.6 Million by 2028 | FMI Analysis
fmiblog.com - April 4 at 6:23 PM
Aesthetic Implants Market on Track for Remarkable Expansion, Forecasted to Surpass USD 10 Billion by 2032 | Market.usAesthetic Implants Market on Track for Remarkable Expansion, Forecasted to Surpass USD 10 Billion by 2032 | Market.us
pharmiweb.com - April 4 at 8:22 AM
Sientra Sells Business Parts for $50M+Sientra Sells Business Parts for $50M+
ocbj.com - April 3 at 3:53 PM
Sientra, Inc.: Sientra Announces Completion and Winning Bidders of its Section 363 Sales AuctionSientra, Inc.: Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction
finanznachrichten.de - April 3 at 10:53 AM
Nuance Medical Agrees to Acquire BIOCORNEUM Scar Treatment BrandNuance Medical Agrees to Acquire BIOCORNEUM Scar Treatment Brand
finance.yahoo.com - April 3 at 10:53 AM
Sientra Announces Completion and Winning Bidders of its Section 363 Sales AuctionSientra Announces Completion and Winning Bidders of its Section 363 Sales Auction
globenewswire.com - April 2 at 6:30 PM
Global Gynecomastia Procedures Market Size To Exceed USD 1900 Million by 2033 | CAGR Of 8.05%Global Gynecomastia Procedures Market Size To Exceed USD 1900 Million by 2033 | CAGR Of 8.05%
finance.yahoo.com - March 15 at 4:23 AM
Global Cosmetic Implants Market, with a special focus on dental implants, is anticipated to hit a remarkable US$ 17.9 Billion by 2032Global Cosmetic Implants Market, with a special focus on dental implants, is anticipated to hit a remarkable US$ 17.9 Billion by 2032
fmiblog.com - March 14 at 11:23 PM
Firm Retention Summary: SientraFirm Retention Summary: Sientra
wsj.com - March 7 at 3:39 PM
Sientra Declares Bankruptcy, Seeks BuyerSientra Declares Bankruptcy, Seeks Buyer
ocbj.com - February 26 at 7:00 PM
Global Extremity Tissue Expanders Industry Poised for a Meteoric Rise, Anticipating US$ 1,842.6 Million with a Resounding 6.3% CAGR by 2028 | FMIGlobal Extremity Tissue Expanders Industry Poised for a Meteoric Rise, Anticipating US$ 1,842.6 Million with a Resounding 6.3% CAGR by 2028 | FMI
fmiblog.com - February 21 at 3:22 PM
SIEN Mar 2024 2.500 callSIEN Mar 2024 2.500 call
finance.yahoo.com - February 17 at 8:46 AM
Sientra, Inc.: Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 ProcessSientra, Inc.: Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
finanznachrichten.de - February 15 at 3:24 PM
Plastic surgery company goes bust, files Chapter 11 bankruptcyPlastic surgery company goes bust, files Chapter 11 bankruptcy
msn.com - February 15 at 3:24 PM
Plastic-surgery company goes bust, files Chapter 11 bankruptcyPlastic-surgery company goes bust, files Chapter 11 bankruptcy
msn.com - February 15 at 10:23 AM
Implant Maker Sientra Cleared to Draw Deerfield Bankruptcy LoanImplant Maker Sientra Cleared to Draw Deerfield Bankruptcy Loan
msn.com - February 14 at 6:42 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

CollPlant Biotechnologies logo

CollPlant Biotechnologies

NASDAQ:CLGN
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; Tel Aviv University; Sheba Medical Center; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Invacare logo

Invacare

NYSE:IVC
Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.
Lakeland Industries logo

Lakeland Industries

NASDAQ:LAKE
Lakeland Industries, Inc. manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks. The company provides durable woven garments, including electrostatic dissipative apparel used in electronics clean rooms; flame resistant meta aramid, para aramid, and FR cotton coveralls/pants/jackets used in petrochemical, refining operations, and electrical utilities; FR fabrics; and cotton and polycotton coveralls, lab coats, pants, and shirts. In addition, it provides high visibility clothing comprising reflective apparel, including vests, T-shirts, sweatshirts, jackets, coats, raingear, jumpsuits, hats, and gloves; and gloves and sleeves that are used in the automotive, glass, and metal fabrication industries. The company sells its products to a network of safety and industrial supply distributors through in-house sales teams, customer service group, and independent sales representatives. It serves end users, such as integrated oil, chemical/petrochemical, automobile, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical, and high technology electronics manufacturers, as well as scientific, medical laboratories, and the utilities industry; and federal, state, and local governmental agencies and departments. Lakeland Industries, Inc. was incorporated in 1982 and is headquartered in Huntsville, Alabama.
RTI Surgical logo

RTI Surgical

NASDAQ:RTIX
Surgalign Holdings, Inc. is a global medical technology company, which engages in designing, developing and manufacturing biologic metal and synthetic implants worldwide. It focuses on delivering spine solutions that drive clinical and economic outcomes. The company markets its products throughout the United States and other countries worldwide through an expanding network of independent distributors. The company was founded in February 1998 and is headquartered in Deerfield, IL.
Sientra logo

Sientra

NASDAQ:SIEN
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.